Stents Market Size, Analysis, Growth, Trends, Revenue, Demand, Challenges and Future Outlook
Stents Market Size- By Product, By Material, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Jan-2025 | Report ID: HLCA2527 | Pages: 1 - 245 | Formats*: |
| Category : Healthcare | |||
Stents Market Introduction and Overview
According to SPER Market Research, the Global Stents Market is estimated to reach USD 21.68 billion by 2034 with a CAGR of 3.95%.
The rising incidence of coronary artery disease, improvements in stent technology, and increased spending on healthcare and research development by both public and private entities are the main factors propelling the growth of the worldwide stents market. The market is growing as a result of the need for drug-eluting stents. One of the most prevalent heart diseases, coronary artery disease has a significant death rate, which highlights the need for efficient treatment options. The market is expanding because to the increased availability of percutaneous coronary intervention (PCI) procedures and technological advancements in medical infrastructure. The market for stents is also anticipated to rise as a result of the increasing number of medication approvals. However, during the projection period, the market's growth may be constrained by the high cost of stent treatments.
By Product: Based on the product, the coronary stents segment led the stents market in 2024. This trend is anticipated to persist throughout the forecast period due to the rise in the prevalence of coronary artery disease, technological advancements in the biotechnology and pharmaceutical industries, and the increased use of drug-eluting stents. However, due to the rising incidence of peripheral artery disease and the expansion of major stent manufacturing companies, the peripheral stents market is anticipated to develop significantly over the course of the projected period.
By Material: Based on material, in 2024, the metallic materials segment led the stents market, and this trend is expected to continue during the forecast period. The dominance of this segment is driven by the increasing prevalence of cardiovascular diseases, the growing number of key players manufacturing metallic stents, and the rise in surgical procedures like fluoroscopy and endoscopy. However, the polymeric biomaterials segment is projected to experience significant growth in the coming years. This growth is attributed to the rising prevalence of cardiovascular diseases, increased focus by companies on developing and producing polymeric stents, and a greater number of government approvals for the development of polymer-based stents.
By End Use: The hospital segment led the stents market in 2024 and is anticipated to continue to do so throughout the forecast period. This is brought on by the rising incidence of coronary artery diseases, government programs to improve healthcare facilities, heightened knowledge on how to treat and manage illnesses, and the trend toward more sedentary lifestyles. However, due to the growing demand for angioplasty treatments and improvements in healthcare technology, the ambulatory surgery centers market is anticipated to rise significantly over the next several years.
By Region: North America dominated the stents market in 2024 and is anticipated to continue to do so for the duration of the projection. The increasing incidence of cardiovascular disorders, the rise in stent product approvals, the development of healthcare infrastructure, the presence of major stent manufacturers, and technological improvements in the healthcare industry in the region are all responsible for this. But throughout the course of the forecast period, the Asia-Pacific area is expected to expand at the fastest rate due to factors like rising healthcare costs, a shift toward unhealthy lifestyles, an aging population, and the incidence of coronary heart disease.
Recent Developments:
- Abbott introduced the XIENCE Sierra, a novel coronary stent system intended to treat artery blockages, in India in May 2024. For complicated cardiac conditions, this XIENCE family addition provides enhanced safety. Abbott's inventions have continuously improved the field of angioplasty, which is a technique to open blocked or constricted arteries.
- Leading coronary stent supplier Translumina Therapeutics began operations in the United Arab Emirates in September 2024. Advanced drug-eluting stent technologies, such as the most researched DES in the world, have been developed through their partnership with the prestigious German Heart Center and supported by more than 10 years of safety and effectiveness studies.
Market Competitive Landscape:
The Global Stents Market is highly consolidated. Some of the market players are Abbott Laboratories, B. Braun Melsungen AG, BD, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Medtronic Plc, Meril Life Science, MicroPort Scientific Corporation, Stryker, Terumo Corporation, W.L Gore & Associates, and Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By Material, By End Use. |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe. |
| Companies Covered | Abbott Laboratories, B. Braun Melsungen AG, BD, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Medtronic Plc, Meril Life Science, MicroPort Scientific Corporation, Stryker, Terumo Corporation, W.L Gore & Associates, and Others. |
Key Topics Covered in the Report:
- Global Stents Market Size (FY’2021-FY’2034)
- Overview of Global Stents Market
- Segmentation of Global Stents Market By Product (Coronary Stents, Peripheral Stents, Stent Related Implant)
- Segmentation of Global Stents Market By Material (Metallic Biomaterial, Polymer Biomaterial, Natural Biomaterial)
- Segmentation of Global Stents Market By End Use (Hospital, Ambulatory Surgical Centers, Others)
- Statistical Snap of Global Stents Market
- Expansion Analysis of Global Stents Market
- Problems and Obstacles in Global Stents Market
- Competitive Landscape in the Global Stents Market
- Details on Current Investment in Global Stents Market
- Competitive Analysis of Global Stents Market
- Prominent Players in the Global Stents Market
- SWOT Analysis of Global Stents Market
- Global Stents Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPERs internal database2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Stents Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Stents Market
7. Global Stents Market, By Product (USD Million) 2021-2034
7.1. Coronary Stents
7.1.1. Drug-eluting stents (DES)7.1.2. Bare-metal coronary stents7.1.3. Bioabsorbable stents
7.2. Peripheral Stents
7.2.1. Iliac stent7.2.2. Femoral-popliteal stents7.2.3. Renal & related stents7.2.4. Carotid stents
7.3. Stent Related Implant
7.3.1. Synthetic grafts7.3.2. Vena cava filters
8. Global Stents Market, By Material (USD Million) 2021-2034
8.1. Metallic Biomaterial8.2. Polymer Biomaterial8.3. Natural Biomaterial
9. Global Stents Market, By End User (USD Million) 2021-2034
9.1. Hospital9.2. Ambulatory Surgical Centers9.3. Others
10. Global Stents Market (USD Million) 2021-2034
10.1. Global Stents Market Size and Market Share
11. Global Stents Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia11.1.2. China11.1.3. India11.1.4. Japan11.1.5. South Korea11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France11.2.2. Germany11.2.3. Italy11.2.4. Spain11.2.5. United Kingdom11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia11.3.2. United Arab Emirates11.3.3. Qatar11.3.4. South Africa11.3.5. Egypt11.3.6. Morocco11.3.7. Nigeria11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada11.4.2. Mexico11.4.3. United States
11.5. Latin America
11.5.1. Argentina11.5.2. Brazil11.5.3. Rest of Latin America
12. Company Profile
12.1. Abbott Laboratories
12.1.1. Company details12.1.2. Financial outlook12.1.3. Product summary12.1.4. Recent developments
12.2. B. Braun Melsungen AG
12.2.1. Company details12.2.2. Financial outlook12.2.3. Product summary12.2.4. Recent developments
12.3. BD
12.3.1. Company details12.3.2. Financial outlook12.3.3. Product summary12.3.4. Recent developments
12.4. Biosensors International Group, Ltd.
12.4.1. Company details12.4.2. Financial outlook12.4.3. Product summary12.4.4. Recent developments
12.5. Biotronik SE & Co. KG
12.5.1. Company details12.5.2. Financial outlook12.5.3. Product summary12.5.4. Recent developments
12.6. Boston Scientific Corporation
12.6.1. Company details12.6.2. Financial outlook12.6.3. Product summary12.6.4. Recent developments
12.7. Elixir Medical Corporation
12.7.1. Company details12.7.2. Financial outlook12.7.3. Product summary12.7.4. Recent developments
12.8. Medtronic Plc
12.8.1. Company details12.8.2. Financial outlook12.8.3. Product summary12.8.4. Recent developments
12.9. Meril Life Science
12.9.1. Company details12.9.2. Financial outlook12.9.3. Product summary12.9.4. Recent developments
12.10. MicroPort Scientific Corporation
12.10.1. Company details12.10.2. Financial outlook12.10.3. Product summary12.10.4. Recent developments
12.11. Stryker
12.11.1. Company details12.11.2. Financial outlook12.11.3. Product summary12.11.4. Recent developments
12.12. Terumo Corporation
12.12.1. Company details12.12.2. Financial outlook12.12.3. Product summary12.12.4. Recent developments
12.13. W.L Gore & Associates
12.13.1. Company details12.13.2. Financial outlook12.13.3. Product summary12.13.4. Recent developments
12.14. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Stents Market CAGR of 3.95% during the forecast period.
Stents Market size is USD 21.68 billion from 2025 to 2034.
Stents Market is covered By Product, By Material, By End Use.
Stents Market is projected to reach USD 21.68 billion by 2034, growing at a CAGR of 3.95% during the forecast period.
Stents Market grew in Market size from 2025. The Market is expected to reach USD 21.68 billion by 2034, at a CAGR of 3.95% during the forecast period.
You can get the sample pages by clicking the link - Click Here
The North America is anticipated to have the highest Market share in the Stents Market.
The key players in the Market include Companies Covered Abbott Laboratories, B. Braun Melsungen AG, BD, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Medtronic Plc, Meril Life Science, MicroPort Scientific Corporation, Stryker, Terumo Corporation, W.L Gore & Associates, and Others. And Others.
The market is growing as a result of the need for drug-eluting stents. One of the most prevalent heart diseases, coronary artery disease has a significant death rate, which highlights the need for efficient treatment options. The market is expanding because to the increased availability of percutaneous coronary intervention (PCI) procedures and technological advancements in medical infrastructure.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
